Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins
Conditions: Cardiovascular Diseases; Dyslipidemias; Statin Adverse Reaction; Pharmacogenic Myopathy Interventions: Other: Preemptive pharmacogenetic atorvastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic simvastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic pitavastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic rosuvastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic pravastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic lovastatin dose based on CPIC guidelines; Other: Preemptive pharmacogenetic fluvastatin dose ...
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas
Condition: Malignant Melanoma Interventions: Drug: Fluvastatin; Other: RNA-sequencing; Other: Gene expression profiling Sponsor: Case Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2020 Category: Research Source Type: clinical trials
Drug-Drug Interaction Between Rifampin and Fluvastatin
Condition: Drug-drug Interaction Intervention: Drug: Intravenous Rifampin Sponsor: University of California, San Francisco Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2019 Category: Research Source Type: clinical trials
